Saturday , September 25 2021

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg

Mumbai (Maharashtra) [India], November 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf®1 Capsules, 0.5 mg, 1 mg and 5 mg, of Astellas Pharm US, Inc.Mumbai (Maharashtra) [India], November 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg, the generic version of Prograf®1 Capsules, 0.5 mg, 1 mg and 5 mg, of Astellas Pharm US, Inc.Read More

About

Check Also

Social impact venture Charitnation helps more than 25000 families of migrant and daily wage earners during Covid-19 crisis in India

New Delhi [India], September 15 (ANI/SRV Media): India was put in lockdown to halt the …

Leave a Reply

Your email address will not be published. Required fields are marked *